(JDEP) Jde Peets - Overview
Stock: Coffee, Tea, Capsules, Instant, Roast
Dividends
| Dividend Yield | 2.66% |
| Yield on Cost 5y | 2.61% |
| Yield CAGR 5y | 19.76% |
| Payout Consistency | 98.3% |
| Payout Ratio | 59.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 4.04% |
| Relative Tail Risk | -15.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.63 |
| Alpha | 98.01 |
| Character TTM | |
|---|---|
| Beta | -0.165 |
| Beta Downside | 0.137 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.15% |
| CAGR/Max DD | 0.21 |
Description: JDEP Jde Peets January 02, 2026
JDE Peet’s N.V. (ticker JDEP) is a global coffee-and-tea company organized into four geographic segments-Europe, LARMEA, APAC, and the Peet’s unit. Its product portfolio spans roast-and-ground coffee (multi-serve and single-serve pods), instant coffee, whole-bean beans, tea, and related hot-beverage equipment, sold under well-known brands such as L’OR, Douwe Egberts, Jacobs, Senseo, Tassimo, Peet’s, and Moccona.
The firm serves both B2B channels (offices, hotels, bars, restaurants) and consumer-facing coffee shops, leveraging a mixed-model distribution that includes retail, food-service, and direct-to-consumer e-commerce. Headquartered in Amsterdam and founded in 1753, JDE Peet’s is currently a subsidiary of Acorn Holdings B.V.
**Key metrics (FY 2023)**: reported revenue of roughly €7.2 billion, with an adjusted EBITDA margin of ~15 % and a modest same-store sales growth of 3 % in its core European market. The company’s exposure to coffee-bean price volatility is mitigated by long-term supply contracts, but a 10 % rise in global coffee prices would still compress margins by an estimated 0.5 %-1 %.
**Sector drivers**: (1) Accelerating consumer shift toward premium and specialty coffee, especially in APAC, is expanding the addressable market at a CAGR of ~6 % (2022-2027). (2) Inflationary pressure on discretionary spending can dampen volume growth, making price-elasticity a critical risk factor. (3) ESG considerations-particularly sustainable sourcing certifications-are increasingly influencing purchasing decisions and can unlock pricing premiums.
For a deeper quantitative view of JDEP’s valuation metrics, a quick look at ValueRay’s analyst toolkit can be useful.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 5.01 > 1.0 |
| NWC/Revenue: -15.33% < 20% (prev -7.47%; Δ -7.86% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.71b > Net Income 1.15b |
| Net Debt (3.96b) to EBITDA (2.65b): 1.49 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (497.0m) vs 12m ago 0.98% < -2% |
| Gross Margin: 34.67% > 18% (prev 0.37%; Δ 3430 % > 0.5%) |
| Asset Turnover: 77.52% > 50% (prev 53.32%; Δ 24.20% > 0%) |
| Interest Coverage Ratio: 5.18 > 6 (EBITDA TTM 2.65b / Interest Expense TTM 340.0m) |
Altman Z'' 0.09
| A: -0.12 (Total Current Assets 4.25b - Total Current Liabilities 7.02b) / Total Assets 23.52b |
| B: 0.08 (Retained Earnings 1.85b / Total Assets 23.52b) |
| C: 0.08 (EBIT TTM 1.76b / Avg Total Assets 23.33b) |
| D: 0.09 (Book Value of Equity 1.17b / Total Liabilities 12.69b) |
| Altman-Z'' Score: 0.09 = B |
Beneish M -2.39
| DSRI: 1.37 (Receivables 1.08b/540.0m, Revenue 18.09b/12.34b) |
| GMI: 1.07 (GM 34.67% / 37.22%) |
| AQI: 1.00 (AQ_t 0.74 / AQ_t-1 0.75) |
| SGI: 1.47 (Revenue 18.09b / 12.34b) |
| TATA: -0.07 (NI 1.15b - CFO 2.71b) / TA 23.52b) |
| Beneish M-Score: -2.39 (Cap -4..+1) = BBB |
What is the price of JDEP shares?
Over the past week, the price has changed by +0.19%, over one month by +0.57%, over three months by +1.46% and over the past year by +102.32%.
Is JDEP a buy, sell or hold?
What are the forecasts/targets for the JDEP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.7 | -3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 35.2 | 11% |
JDEP Fundamental Data Overview February 04, 2026
P/E Trailing = 25.7236
P/E Forward = 16.2075
P/S = 1.5866
P/B = 1.4224
P/EG = 1.257
Revenue TTM = 18.09b EUR
EBIT TTM = 1.76b EUR
EBITDA TTM = 2.65b EUR
Long Term Debt = 4.09b EUR (estimated: total debt 4.90b - short term 811.0m)
Short Term Debt = 811.0m EUR (from shortTermDebt, last quarter)
Debt = 4.90b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.96b EUR (from netDebt column, last quarter)
Enterprise Value = 19.31b EUR (15.35b + Debt 4.90b - CCE 937.0m)
Interest Coverage Ratio = 5.18 (Ebit TTM 1.76b / Interest Expense TTM 340.0m)
EV/FCF = 8.88x (Enterprise Value 19.31b / FCF TTM 2.17b)
FCF Yield = 11.26% (FCF TTM 2.17b / Enterprise Value 19.31b)
FCF Margin = 12.02% (FCF TTM 2.17b / Revenue TTM 18.09b)
Net Margin = 6.36% (Net Income TTM 1.15b / Revenue TTM 18.09b)
Gross Margin = 34.67% ((Revenue TTM 18.09b - Cost of Revenue TTM 11.81b) / Revenue TTM)
Gross Margin QoQ = 30.47% (prev 34.02%)
Tobins Q-Ratio = 0.82 (Enterprise Value 19.31b / Total Assets 23.52b)
Interest Expense / Debt = 1.41% (Interest Expense 69.0m / Debt 4.90b)
Taxrate = 19.47% (102.0m / 524.0m)
NOPAT = 1.42b (EBIT 1.76b * (1 - 19.47%))
Current Ratio = 0.61 (Total Current Assets 4.25b / Total Current Liabilities 7.02b)
Debt / Equity = 0.45 (Debt 4.90b / totalStockholderEquity, last quarter 10.78b)
Debt / EBITDA = 1.49 (Net Debt 3.96b / EBITDA 2.65b)
Debt / FCF = 1.82 (Net Debt 3.96b / FCF TTM 2.17b)
Total Stockholder Equity = 10.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.93% (Net Income 1.15b / Total Assets 23.52b)
RoE = 10.50% (Net Income TTM 1.15b / Total Stockholder Equity 10.95b)
RoCE = 11.71% (EBIT 1.76b / Capital Employed (Equity 10.95b + L.T.Debt 4.09b))
RoIC = 12.95% (NOPAT 1.42b / Invested Capital 10.95b)
WACC = 4.30% (E(15.35b)/V(20.24b) * Re(5.31%) + D(4.90b)/V(20.24b) * Rd(1.41%) * (1-Tc(0.19)))
Discount Rate = 5.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.49%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈1.70b ; Y1≈2.09b ; Y5≈3.56b
Fair Price DCF = 205.7 (EV 103.73b - Net Debt 3.96b = Equity 99.77b / Shares 485.0m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 2.70 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 26.44 | Revenue CAGR: 13.89% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=1.88 | Chg30d=-0.008 | Revisions Net=+0 | Growth EPS=-3.6% | Growth Revenue=+2.0%